What does it truly mean to practice patient-centered research, and how can we ensure patient voices drive real healthcare change? In this episode of The Value Brief, host Larragem Raines, Director of Research at the Center for Innovation and Value Research, is joined by two leaders in the field:

• Dr. C. Daniel Mullins, Executive Director of the PATIENTS Program at the University of Maryland School of Pharmacy
• Dr. Magdalena Harrington, Senior Director of Patient-Centered Outcomes Assessment at Pfizer

Together they discuss:

• Defining patient-centered value beyond clinical outcomes
• Turning patient insights into measurable, actionable healthcare improvements
• The essential role of trust, communication, and storytelling in patient engagement
• Moving from patient participation to true co-creation in healthcare research
• What gives them hope—and urgency—for the future of value assessment

This thoughtful conversation offers practical strategies for translating lived experiences into research, improving outcomes, and advancing equity in healthcare evaluation.

Listen now to learn how patient voices can drive lasting change in healthcare systems.

Learn more: Methods Summit Summary

Patient engagement is essential for better health outcomes, but what does authentic engagement look like? In this episode of The Value Brief, Swapna Kakani, co-founder, The Gutsy Perspective, and Greg Martin, Chief Officer, Engagement, Dissemination, and Implementation at Patient-Centered Outcomes Research Institute (PCORI), share insights on breaking down barriers, fostering trust, and shaping healthcare solutions that reflect patient voices.

Join host Jason Spangler as we explore grassroots advocacy, real-world collaboration, and PCORI’s efforts to drive patient-centered research.

Provide input on the Blueprint for Patient-Centered Value Research—a resource designed to foster meaningful partnerships with patients throughout value research. Open Public Comment Period: March 4 - April 4, 2025. Learn more.

In this second part of our conversation with Adrian Kielhorn (Alexion, AstraZeneca Rare Disease) and Charlene Son Rigby (CEO of Global Genes), we continue exploring the challenges and opportunities in rare disease patient engagement. This episode examines the role of pharmaceutical companies and healthcare providers in building trust, the importance of transparency, and the impact of real-world evidence, AI, and emerging technology on patient outcomes.

Register for the Center for Innovation & Value Research's 6th Annual Methods Summit, March 19, 2025:

On-Site Registration: https://ow.ly/T59550UUorW
Live-Stream Registration: https://ow.ly/CAMH50UUorU